CNS Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGCNS Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 69), indicating performance broadly in line with the market. Earnings growth of 61% provides fundamental context to the price action. Investors should exercise caution due to high volatility (94% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.71 | -15.55% | BELOW |
| 50 SMA | $4.58 | -13.06% | BELOW |
| 100 SMA | $3.78 | +5.31% | ABOVE |
| 150 SMA | $4.66 | -14.53% | BELOW |
| 200 SMA | $5.55 | -28.35% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CNSP in an uptrend right now?
CNSP has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is CNSP overbought or oversold?
CNSP's RSI (14) is 41. The stock is in neutral territory, neither overbought nor oversold.
Is CNSP outperforming the market?
CNSP has a Relative Strength (RS) Rating of 69 out of 99. CNSP is performing about average compared to the market.
Where is CNSP in its 52-week range?
CNSP is trading at $3.98, which is 32% of its 52-week high ($12.36) and 20% above its 52-week low ($1.90).
How volatile is CNSP?
CNSP has a Beta of 0.99 and 52-week volatility of 94%. It's less volatile than the S&P 500 - generally more stable.